Skip to content
10-Q

Quarterly Report

Beam Therapeutics Inc. BEAM

0001193125-25-263542

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 28, 2025 101.47M sh
Shares Diluted Q3 2025 · Sep 30, 2025 102.57M sh
Shares Diluted Q3 2025 · Sep 30, 2025 97.57M sh
Shares Diluted Q3 2025 · Sep 30, 2024 82.41M sh
Shares Diluted Q3 2025 · Sep 30, 2024 82.14M sh
Capex Q3 2025 · Sep 30, 2025 $11.21M
Capex Q3 2025 · Sep 30, 2024 $5.98M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$261.81M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$270.88M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $267.96M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $281.97M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $230.2M
Stockholders Equity Q3 2025 · Sep 30, 2025 $966M
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.05B
Stockholders Equity Q3 2025 · Mar 31, 2025 $1.12B
Stockholders Equity Q3 2025 · Dec 31, 2024 $733.55M
Stockholders Equity Q3 2025 · Sep 30, 2024 $791.32M
Stockholders Equity Q3 2025 · Jun 30, 2024 $854.09M
Stockholders Equity Q3 2025 · Mar 31, 2024 $913.49M
Stockholders Equity Q3 2025 · Dec 31, 2023 $981.33M
Current Liabilities Q3 2025 · Sep 30, 2025 $182.56M
Current Liabilities Q3 2025 · Dec 31, 2024 $182.07M
Total Liabilities Q3 2025 · Sep 30, 2025 $345.08M
Total Liabilities Q3 2025 · Dec 31, 2024 $370.28M
Current Assets Q3 2025 · Sep 30, 2025 $1.1B
Current Assets Q3 2025 · Dec 31, 2024 $878.15M
Total Assets Q3 2025 · Sep 30, 2025 $1.31B
Total Assets Q3 2025 · Dec 31, 2024 $1.1B
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.10
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.32
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.17
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.49
Eps Basic Q3 2025 · Sep 30, 2025 −$1.10
Eps Basic Q3 2025 · Sep 30, 2025 −$3.32
Eps Basic Q3 2025 · Sep 30, 2024 −$1.17
Eps Basic Q3 2025 · Sep 30, 2024 −$3.49
Sga Expense Q3 2025 · Sep 30, 2025 $26.74M
Sga Expense Q3 2025 · Sep 30, 2025 $81.54M
Sga Expense Q3 2025 · Sep 30, 2024 $26.52M
Sga Expense Q3 2025 · Sep 30, 2024 $82.87M
Rd Expense Q3 2025 · Sep 30, 2025 $109.77M
Rd Expense Q3 2025 · Sep 30, 2025 $310.34M
Rd Expense Q3 2025 · Sep 30, 2024 $94.26M
Rd Expense Q3 2025 · Sep 30, 2024 $266.12M
Net Income Q3 2025 · Sep 30, 2025 −$112.73M
Net Income Q3 2025 · Sep 30, 2025 −$324.29M
Net Income Q3 2025 · Jun 30, 2025 −$102.29M
Net Income Q3 2025 · Mar 31, 2025 −$109.27M
Net Income Q3 2025 · Sep 30, 2024 −$96.67M
Net Income Q3 2025 · Sep 30, 2024 −$286.39M
Net Income Q3 2025 · Jun 30, 2024 −$91.05M
Net Income Q3 2025 · Mar 31, 2024 −$98.67M
Operating Income Q3 2025 · Sep 30, 2025 −$126.81M
Operating Income Q3 2025 · Sep 30, 2025 −$366.25M
Operating Income Q3 2025 · Sep 30, 2024 −$106.5M
Operating Income Q3 2025 · Sep 30, 2024 −$315.53M
Revenue Q3 2025 · Sep 30, 2025 $9.7M
Revenue Q3 2025 · Sep 30, 2025 $25.63M
Revenue Q3 2025 · Sep 30, 2024 $14.27M
Revenue Q3 2025 · Sep 30, 2024 $33.45M